Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("VERMEIRE, Severine")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 73

  • Page / 3
Export

Selection :

  • and

Mucosal healing in inflammatory bowel diseuse : impossible ideal or therapeutic target?RUTGEERTS, Paul; VERMEIRE, Severine; VAN ASSCHE, Gert et al.Gut. 2007, Vol 56, Num 4, pp 453-455, issn 0017-5749, 3 p.Article

Management of acute severe ulcerative colitisVAN ASSCHE, Gert; VERMEIRE, Séverine; RUTGEERTS, Paul et al.Gut. 2011, Vol 60, Num 1, pp 130-133, issn 0017-5749, 4 p.Article

Rôle de la cicatrisation muqueuse dans les MICIVAN ASSCHE, Gert; VERMEIRE, Séverine; RUTGEERTS, Paul et al.Hépato-gastro (Montrouge). 2008, Vol 15, Num JUIN, pp 20-25, issn 1253-7020, 6 p., NSArticle

Drug safety evaluation of certolizumab pegolFERRANTE, Marc; VERMEIRE, Séverine; RUTGEERTS, Paul J et al.Expert opinion on drug safety. 2014, Vol 13, Num 2, pp 255-266, issn 1474-0338, 12 p.Article

The impact of uridine diphosphate- glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipientsKUYPERS, Dirk R. J; NAESENS, Maarten; VERMEIRE, Severine et al.Clinical pharmacology and therapeutics. 2005, Vol 78, Num 4, pp 351-361, issn 0009-9236, 11 p.Article

Infliximab therapy for patients with inflammatory bowel disease: 10 years onVAN ASSCHE, Gert; VERMEIRE, Séverine; RUTGEERTS, Paul et al.European journal of pharmacology. 2009, Vol 623, issn 0014-2999, S17-S25, NSArticle

L'infliximab dans le traitement prolongé de la maladie de Crohn non fistulisante = Long term treatment with infliximab in non-fistulising Crohn's diseaseVERMEIRE, Séverine; VAN ASSCHE, G; RUTGEERTS, P et al.Acta endoscopica. 2007, Vol 37, Num 3, pp 271-283, issn 0240-642X, 13 p.Article

Focus on mechanisms of inflammation in inflammatory bowel disease sites of inhibition : Current and future therapiesVAN ASSCHE, Gert; VERMEIRE, Séverine; RUTGEERTS, Paul et al.Gastroenterology clinics of North America. 2006, Vol 35, Num 4, issn 0889-8553, v, 743-756 [15 p.]Article

Diagnostic value of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseasePEETERS, Marc; JOOSSENS, Sofie; VERMEIRE, Severine et al.The American journal of gastroenterology. 2001, Vol 96, Num 3, pp 730-734, issn 0002-9270Article

(Auto)Antibodies in Inflammatory Bowel DiseasesVERMEIRE, Severine; VERMEULEN, Nathalie; VAN ASSCHE, Gert et al.Gastroenterology clinics of North America. 2008, Vol 37, Num 2, issn 0889-8553, vii, 429-438 [11 p.]Article

Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel diseaseHENCKAERTS, Liesbet; PIERIK, Marie; JOOSSENS, Marie et al.Gut. 2007, Vol 56, Num 11, pp 1536-1542, issn 0017-5749, 7 p.Article

Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's diseaseBAERT, Filip; NOMAN, Maja; VERMEIRE, Severine et al.The New England journal of medicine. 2003, Vol 348, Num 7, pp 601-608, issn 0028-4793, 8 p.Article

Common variants in the NLRP3 region contribute to Crohn's disease susceptibilityVILLANI, Mexandra-Chloé; LEMIRE, Mathieu; GAUDET, Daniel et al.Nature genetics. 2009, Vol 41, Num 1, pp 71-76, issn 1061-4036, 6 p.Article

The Crohn's disease susceptibility gene DLG5 as a member of the CARD interaction networkFRIEDRICHS, Frauke; HENCKAERTS, Liesbet; VERMEIRE, Severine et al.Journal of molecular medicine (Berlin. Print). 2008, Vol 86, Num 4, pp 423-432, issn 0946-2716, 10 p.Article

Does pregnancy change the disease course? A study in a european cohort of patients with inflammatory bowel diseaseRIIS, Lene; VIND, Ida; ODES, Selwyn et al.The American journal of gastroenterology. 2006, Vol 101, Num 7, pp 1539-1545, issn 0002-9270, 7 p.Article

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trialVERMEIRE, Severine; O'BYRNE, Sharon; BAUMGART, Daniel C et al.Lancet (British edition). 2014, Vol 384, Num 9940, pp 309-318, issn 0140-6736, 10 p.Article

Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relativesJOOSSENS, Marie; HUYS, Geert; CNOCKAERT, Margo et al.Gut. 2011, Vol 60, Num 5, pp 631-637, issn 0017-5749, 7 p.Article

Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug useHAZES, Johanna M. W; COULIE, Pierre G; GEENEN, Vincent et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 11, pp 1955-1968, issn 1462-0324, 14 p.Article

Anti-α-enolase Antibodies in Patients with Inflammatory Bowel DiseaseVERMEULEN, Nathalie; ARIJS, Ingrid; RUTGEERTS, Paul et al.Clinical chemistry (Baltimore, Md.). 2008, Vol 54, Num 3, pp 534-541, issn 0009-9147, 8 p.Article

Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease. CommentaryHANAUER, Stephen B; VERMEIRE, Severine; NOMAN, Maja et al.Gut. 2007, Vol 56, Num 9, issn 0017-5749, 1181-1183, 1226-1231 [9 p.]Article

Treatment inferred disease severity in Crohn's disease : Evidence for a European gradient of disease courseWOLTERS, Frank L; JOLING, Catelijne; O'MORAIN, Colm et al.Scandinavian journal of gastroenterology. 2007, Vol 42, Num 3, pp 333-344, issn 0036-5521, 12 p.Article

Diagnostic accuracy of Ten second-generation (human) tissue transglutaminase antibody assays in celiac diseaseVAN MEENSEL, Britta; HIELE, Martin; HOFFMAN, Ilse et al.Clinical chemistry (Baltimore, Md.). 2004, Vol 50, Num 11, pp 2125-2135, issn 0009-9147, 11 p.Article

Transmission of CARD 15 (NOD2) variants within families of patients with inflammatory bowel diseaseESTERS, Nele; PIERIK, Marie; VAN STEEN, Kristel et al.The American journal of gastroenterology. 2004, Vol 99, Num 2, pp 299-305, issn 0002-9270, 7 p.Article

Three Ulcerative Colitis Susceptibility Loci Are Associated with Primary Sclerosing Cholangitis and Indicate a Role for IL2, REL, and CARD9JANSE, Marcel; LAMBERTS, Laetitia E; BJÖRNSSON, Einar et al.Hepatology (Baltimore, Md.). 2011, Vol 53, Num 6, pp 1977-1985, issn 0270-9139, 9 p.Article

Genomic Copy Number Determines Functional Expression of β-Defensin 2 in Airway Epithelial Cells and Associates with Chronic Obstructive Pulmonary DiseaseJANSSENS, Wim; NUYTTEN, Hilde; DUPONT, Lieven J et al.American journal of respiratory and critical care medicine. 2010, Vol 182, Num 2, pp 163-169, issn 1073-449X, 7 p.Article

  • Page / 3